-The Business Standard CVC says provide protection to officer, investigate corruption; MCI president denies all allegations Union health minister Harsh Vardhan has kicked up yet another controversy by ordering the removal of the chief vigilance officer of the Medical Council of India (MCI), H K Jethi, instead of providing him protection after he complained of harassment and threats. This is the second time Vardhan has decided to remove an anti-graft officer. Earlier, he...
More »SEARCH RESULT
Total Matching Records found : 3868
NRIs filed 78% of the patent pleas in India -Sushmi Dey
-The Times of India NEW DELHI: India registered the third highest rate for patent filings by non-residents at 78% of the total applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian patent office showed. Canada and Brazil topped the list with 86.6% and 84%, respectively. Officials opine this is an indicator of lack of awareness amongst the domestic industry as well...
More »Key Rajasthan labour reforms get President’s approval -Prashant K Nanda
-Livemint Move will give firms more flexibility in hiring and firing of staff, make tougher the registration of labour unions New Delhi: President Pranab Mukherjee on Friday gave his assent to key labour reforms, including amendments to the Industrial Dispute Act, Contract Labour Act and Factories Act that the Vasundhara Raje-led Rajasthan government had forwarded to the Union government after they were passed in the state assembly two months ago, a central...
More »Delhi's Air Quality Deteriorating Due to Burning of Agricultural Waste
-Outlook New Delhi: The air quality in the national has deteriorated significantly and experts identified burning of agricultural wastes in neighbouring states as one of the major contributors to a visible haze over the city. As per official data, the air quality in the city has slipped into the category of "poor" following rapid increase of PM2.5 (respirable particles) level. The Air Quality Index value, calculated on the basis of PM 2.5 level,...
More »New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh
-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...
More »
